Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motif
Ae. Herman et al., Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motif, J IMMUNOL, 163(11), 1999, pp. 6275-6282
Particular HLA class II allelic sequences are associated with susceptibilit
y to type I diabetes, To understand the mechanism, knowledge of the molecul
ar nature of the specific TCR/peptide/class II interactions involved in the
disease process is required. To this end, we have introduced the diabetes-
associated human class II HLA-DQ8 allele (DQA1*0301/DQB1*0302) as a transge
ne into mice and analyzed T cell responses restricted by this molecule to a
n important Ag in human diabetes, human glutamic acid decarboxylase 65, Hyb
ridomas were used to determine the particular peptides from this Ag present
ed by HLA-DQ8 to T cells and to map the core minimal epitopes required for
T cell stimulation. Analysis of these core epitopes reveals a motif and rel
evant features for peptides that are immunogenic to T cells when presented
by HLA-DQ8, The major immunogenic epitopes of glutamic acid decarboxylase 6
5 do not contain a negatively charged residue that binds in the P9 pocket o
f the HLA-DQ8 molecule. PBMC from HLA-DQ8(+) diabetic and nondiabetic indiv
iduals respond to these peptides, confirming that the mouse model is a usef
ul tool to define epitopes of autoantigens that are processed by human APC
and recognized by human T cells.